Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

002262

Rank in Stocks #4683
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Share Price
$3.20
Market Cap
$3.24B
Change (1 day)
1.52%
Change (1 year)
-12.70%
Country
CN
Trade Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Category

Healthcare
P/S ratio for Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
P/S ratio as of October 2026 TTM: 3.51
According to Jiangsu Nhwa Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.51. At the end of 2023 the company had a P/S ratio of 5.56.
P/S ratio history for Jiangsu Nhwa Pharmaceutical Co., Ltd. from 2005 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 3.51 -18.84%
2024 4.33 -22.16%
2023 5.56 -3.45%
2022 5.75 43.63%
2021 4.01 -16.69%
2020 4.81 69.51%
2019 2.84 24.42%
2018 2.28 -44.19%
2017 4.09 -6.45%
2016 4.37 -13.71%
2015 5.06 29.80%
2014 3.90 -5.58%
2013 4.13 60.76%
2012 2.57 28.59%
2011 2.00 -34.40%
2010 3.05 40.43%
2009 2.17 71.42%
2008 1.27 -46.07%
2007 2.35 22.13%
2006 1.92 13.28%
2005 1.70 0.00%
P/S ratio for similar companies or competitors